Home > Insider Trading > Filing (0001415889-14-002456)

Filing Details

Accession Number:: 0001415889-14-002456
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-13 17:58:50
Reporting Period:: 2014-08-11

Filing Date:: 2014-08-13
Accepted Time:: 2014-08-13 17:58:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1412486	Cocrystal Pharma Inc.	COCP	Pharmaceutical Preparations (2834)	205978559

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
898860	Al Et Md Phillip Frost	4400 Biscayne Blvd. Miami FL 33137		No	No	No	No
1380896	Trust Investments Gamma Frost	4400 Biscayne Blvd. Miami FL 33137		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-11	45,000	$0.29	12,276,525	No	4	P	Indirect	By Frost Gamma Investments Trust
Common Stock	Acquisiton	2014-08-12	66,200	$0.29	12,342,725	No	4	P	Indirect	By Frost Gamma Investments Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Frost Gamma Investments Trust
No	4	P	Indirect	By Frost Gamma Investments Trust

Footnotes

The weighted average price was $0.2891. These shares were purchased in multiple transactions ranging from $0.285 to $0.29, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
Since the reporting person's last report, 3,591,335 shares previously held by The Frost Group, LLC., a limited liability company of which Frost Gamma Investments Trust is a principal member, have been distributed and are now owned by Frost Gamma Investments Trust.
These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The weighted average price was $0.2930. These shares were purchased in multiple transactions ranging from $0.2889 to $0.30, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (4) to this Form 4.